ACTIVE

2PHARMA

Financial year 2025 · closed on 31/12/2025
Net result
120,6 k €
+43.6% YoY
Gross margin
296,2 k €
+118115.1% YoY
Equity
779,5 k €
+18.3% YoY

What does 2PHARMA do?

2PHARMA is a Public limited company incorporated in 2007. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0886.662.746
Incorporation
19/01/2007
Legal form
Public limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
Contributed capital
375 000,00 €
Latest accounts
31/12/2025
Joint committees (2)
  • 119
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 19 financial years

2025202420232022202120202019201820172016201520142013201220112010200920082007
Income statement
Gross margin296,2 k €-251 €33 k €183,8 k €507,5 k €865,6 k €
EBITDA212,3 k €-33,3 k €-10,2 k €-5,2 k €100,2 k €284,9 k €35,5 k €-168,2 k €167,3 k €-18,6 k €160,9 k €500,6 k €204,4 k €304,9 k €217,3 k €48,4 k €141,3 k €-63,5 k €23,4 k €
Operating result162 k €106,3 k €44,4 k €22,5 k €64,2 k €178,5 k €4,7 k €-222,4 k €27,4 k €-274,5 k €36,3 k €361,1 k €53,4 k €165,7 k €144,4 k €3,5 k €108,3 k €-95,6 k €-3,9 k €
Net result120,6 k €84 k €38,1 k €22,2 k €64,1 k €178,1 k €-1,7 k €-238,4 k €19,5 k €-294,2 k €-9,7 k €218,3 k €19,4 k €90,4 k €86,7 k €3,6 k €104,4 k €-95 k €-5,9 k €
Balance sheet
Equity779,5 k €658,8 k €574,8 k €536,8 k €514,6 k €450,6 k €272,4 k €274,2 k €512,6 k €493,1 k €787,3 k €797 k €578,7 k €559,3 k €468,8 k €382,1 k €378,5 k €274,1 k €369,1 k €
Total assets1,1 M €923,3 k €859,7 k €1,1 M €1,7 M €979,8 k €569,3 k €2,1 M €2,3 M €2,8 M €3,3 M €3 M €2,3 M €2,7 M €2,3 M €2,1 M €1,6 M €918,4 k €939,4 k €
Cash756 €3,3 k €3,4 k €94,2 k €1,1 M €217,2 k €77,8 k €632,7 k €636,9 k €631,4 k €380,7 k €415,5 k €253,9 k €556,8 k €568,8 k €574,4 k €388,7 k €157,9 k €203,2 k €
Debts343,3 k €258,1 k €282,1 k €546,4 k €1,1 M €529,3 k €296,9 k €1,8 M €1,7 M €2,3 M €2,5 M €2,2 M €1,7 M €2,1 M €1,8 M €1,7 M €1,2 M €644,3 k €570,3 k €
Other
Workforce0,0 ETP2,3 ETP10,7 ETP10,7 ETP14,2 ETP14,5 ETP13,4 ETP14,4 ETP13,7 ETP12,0 ETP9,0 ETP6,0 ETP5,3 ETP2,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 31 ended

Active mandates

Aquitania

Director · since 30 mars 2026 · until 04 juin 2032 · 0666.678.822

Represented by Anja Imschoot

Active
MD CONSULT

Managing director · since 30 mars 2026 · until 04 juin 2032 · 0471.608.456

Represented by Mario Debel

Active
SDV Consult

Director · since 11 février 2019 · until 30 juin 2025 · 0544.743.684

Represented by Stanny De Vleeschauwer

Active

Ended mandates

Aquitania

Director · since 11 février 2019 · until 17 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 11 février 2019 · until 30 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
MD CONSULT

Managing director · since 11 février 2019 · until 17 juin 2025 · 0471.608.456

Represented by Mario Debel

Ended
MD CONSULT

Managing director · since 11 février 2019 · until 30 juin 2025 · 0471.608.456

Represented by Mario Debel

Ended
At this address

Other companies at this address

CompanyCBE no.
2PHARMA HOLDINGActive
0644.751.377
0474.817.869
0893.541.630
Ceres InvestActive
0775.683.264
Ceres PharmaActive
0641.953.324
0407.326.754
CONESSENCEActive
0819.266.552
0794.812.555
0681.915.443
CREDOPHARActive
0849.730.193
DGPharmaActive
0508.925.544
DRIEPUNTNULActive
1021.711.292
HR ESSENTIALSActive
0721.702.467
KOUTERLOSActive
0450.036.349
LabopharActive
0643.723.177
MD PharmaActive
0667.779.672
PADEL FACTORYActive
0801.951.260
0865.651.952
0884.649.304
0421.364.139
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date09/07/202630/07/202525/07/202431/08/202311/07/202212/07/2021
General meeting16/06/202630/06/202530/06/202429/08/202321/06/202206/07/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

19 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202516/06/202609/07/2026DutchPDF
Abridged model31/12/202430/06/202530/07/2025DutchPDF
Abridged model31/12/202330/06/202425/07/2024DutchPDF
Full model31/12/202229/08/202331/08/2023DutchPDF
Full model31/12/202121/06/202211/07/2022DutchPDF
Full model31/12/202006/07/202112/07/2021DutchPDF
Abridged model31/12/201924/08/202027/08/2020DutchPDF
Abridged model31/12/201802/09/201903/12/2019DutchPDF
Abridged model31/12/201730/06/201825/07/2018DutchPDF
Full model31/12/201620/06/201717/07/2017DutchPDF
Full model31/12/201521/06/201618/07/2016DutchPDF
Full model31/12/201416/06/201517/07/2015DutchPDF
Full model31/12/201317/06/201430/06/2014DutchPDF
Full model31/12/201218/06/201312/07/2013DutchPDF
Full model31/12/201119/06/201227/06/2012DutchPDF
Full model31/12/201021/06/201129/06/2011DutchPDF
Full model31/12/200915/06/201024/06/2010DutchPDF
Full model31/12/200816/06/200906/07/2009DutchPDF
Full model31/12/200717/06/200830/06/2008DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 31 ended

Active mandates

Aquitania

Director · since 30 mars 2026 · until 04 juin 2032 · 0666.678.822

Represented by Anja Imschoot

Active
MD CONSULT

Managing director · since 30 mars 2026 · until 04 juin 2032 · 0471.608.456

Represented by Mario Debel

Active
SDV Consult

Director · since 11 février 2019 · until 30 juin 2025 · 0544.743.684

Represented by Stanny De Vleeschauwer

Active

Ended mandates

Aquitania

Director · since 11 février 2019 · until 17 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
Aquitania

Director · since 11 février 2019 · until 30 juin 2025 · 0666.678.822

Represented by Anja Imschoot

Ended
MD CONSULT

Managing director · since 11 février 2019 · until 17 juin 2025 · 0471.608.456

Represented by Mario Debel

Ended
MD CONSULT

Managing director · since 11 février 2019 · until 30 juin 2025 · 0471.608.456

Represented by Mario Debel

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates29/04/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office15/02/2022
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Registered office19/06/2019
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates27/02/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/08/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/01/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/12/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office02/07/2015
    MAATSCHAPPELIJKE ZETEL
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025120,6 k €
  2. 2024
    Annual accounts 202484 k €
  3. 2023
    Annual accounts 202338,1 k €
  4. 2022
    Annual accounts 202222,2 k €
  5. 2021
    Annual accounts 202164,1 k €
  6. 2020
    Annual accounts 2020178,1 k €
  7. 2019
    Annual accounts 2019-1,7 k €
  8. 2018
    Annual accounts 2018-238,4 k €
  9. 2017
    Annual accounts 201719,5 k €
  10. 2016
    Annual accounts 2016-294,2 k €
  11. 2015
    Annual accounts 2015-9,7 k €
  12. 2014
    Annual accounts 2014218,3 k €
  13. 2013
    Annual accounts 201319,4 k €
  14. 2012
    Annual accounts 201290,4 k €
  15. 2011
    Annual accounts 201186,7 k €
  16. 2010
    Annual accounts 20103,6 k €
  17. 2009
    Annual accounts 2009104,4 k €
  18. 2008
    Annual accounts 2008-95 k €
  19. 2007
    Annual accounts 2007-5,9 k €
  20. 19/01/2007
    IncorporationPublic limited company